Human Trials Tracker - Starting April 2026

Newly registered or updated clinical trials in aging and longevity research.

Trial ID	Intervention	Condition	Phase	Status
NCT06313360 *	OSK therapy (partial reprogramming) Press Release ->	Glaucoma / NAION	I	First patient dosed (May 28, 2026)
NCT06836609	ALN-CIDEB (RNAi)	MASLD / MASH (fatty liver disease)	I	Recruiting

* The OSK trial (NCT06313360) has no current public record on ClinicalTrials.gov. However, the trial is actively enrolling, and the first patient was dosed on May 28, 2026. Source: Life Biosciences press release ->

Updated monthly. Source: ClinicalTrials.gov. Subscribe for monthly digest.

← Back to homepage